There are two main types of lung cancer: small cell and non-small cell. According to the American Cancer Society, non-small ...

This year in review of 2024 milestones in non–small cell lung cancer (NSCLC) features coverage of the LAURA trial presented in June at the American Society of Clinical Oncology meeting in ...

New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a severe form of metastatic brain cancer that spreads to membranes surrounding ...

Bob Uecker's cause of death has not been revealed, but his family said he had been battling small cell lung cancer since early 2023.

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) Biologics License Application (BLA) for datopotamab ...

SMP-3124 is under clinical development by Sumitomo Pharma and currently in Phase II for Non-Small Cell Lung Cancer.

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

BBO-8520, an investigational oral agent, has been granted fast track designation from the FDA in previously treated KRAS G12C ...

The accelerated approval was based on the results of the eNRGy trial of 64 patients with NRG1-positive non–small cell lung cancer and 30 patients with NRG1-positive pancreatic adenocarcinoma.

Tevimbra is under clinical development by BeiGene and currently in Phase I for Urethral Cancer. According to GlobalData, Phase I drugs for Urethral Cancer does not have sufficient historical data to ...

Johnson & Johnson CEO highlights Lecrazas potential to transform lung cancer treatment Johnson & Johnsons leader underscores ...